Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Nitroprusside in Pediatric Hypertension
NCT00621816Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jan 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium nitroprusside in hypertension (HTN), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Change in Mean Arterial Pressure at 30 months. Started Jan 2009; status: completed.
02
Drugs
sodium nitroprusside
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00621816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621816.